Estradiol Side Effects
How can Estradiol Side Effects affect You? | PatientsVille.com
View and Submit Estradiol Side Effects
Your Estradiol Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Alternative ESTRADIOL Names:ACTIVELLA ALORA CLIMARA CLIMARA PRO COMBIPATCH DELESTROGEN DIVIGEL ELESTRIN ESTRACE ESTRASORB ESTRING ESTROGEL EVAMIST FEMRING FEMTRACE MENOSTAR MIMVEY NATAZIA PREFEST VAGIFEM VIVELLE DOT
Active Ingredient: ESTRADIOL
Side Effects reported to FDA: 689. View Estradiol Adverse Reports
Reported deaths: 13
Reported hospitalizations: 74
Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw
AUDIENCE: Consumer, Pharmacy
ISSUE: Sandoz notified the public that it issued a voluntary recall of 10 lots of its generic oral contraceptive Introvale in the US, following a recent report of a packaging flaw. A consumer reported that the white placebo tablets were mistakenly in the ninth row (labeled “Week 9”) of the 13-row blister card, rather than in the correct position in the 13th and final row (labeled “Week 13”). Each three-month blister card contains 84 peach-colored active tablets and seven white placebo tablets in 13 rows, each representing one week. While the white placebo tablets can be clearly distinguished from the peach-colored active tablets, the risk of an unintended pregnancy for a patient taking the wrong tablet over several days cannot be excluded.
The lot numbers involved in the recall are as follows: LF00478C, LF00479C, LF00551C, LF00552C, LF00687C, LF00688C, LF00763C, LF00764C, LF00765C and LF01261C. These lots were distributed only in the US between January 2011 and May 2012.
BACKGROUND: Introvale is an extended-cycle oral contraceptive. Sandoz is not aware of any reports of related adverse events.
RECOMMENDATION: If a patient finds a white placebo tablet in any position other than the 13th and final row (Week 13), they should immediately begin using a non-hormonal form of contraception and contact their healthcare professional.
Healthcare professionals and patients are encouraged to report adverse events, side effects, or quality problems related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
[06/05/2012 - Press Release - Sandoz]
Estradiol Adverse Reactions
Application Site Erythema ( 68 Reports)|Application Site Pruritus ( 68 Reports)|Application Site Rash ( 47 Reports)|Headache ( 46 Reports)|Nausea ( 29 Reports)|Hot Flush ( 27 Reports)|Pain ( 23 Reports)|Rash ( 23 Reports)|Vomiting ( 23 Reports)|Application Site Irritation ( 22 Reports)|Pregnancy On Oral Contraceptive ( 22 Reports)|Fatigue ( 21 Reports)|Pruritus ( 20 Reports)|Breast Cancer ( 19 Reports)|Pain In Extremity ( 19 Reports)|Pulmonary Embolism ( 19 Reports)|Application Site Pain ( 18 Reports)|Breast Cancer Female ( 18 Reports)|Depression ( 18 Reports)|Dizziness ( 18 Reports)|Application Site Vesicles ( 16 Reports)|Metrorrhagia ( 16 Reports)|Diarrhoea ( 15 Reports)|Hypersensitivity ( 15 Reports)|Alopecia ( 14 Reports)|Asthenia ( 14 Reports)|Oedema Peripheral ( 14 Reports)|Anxiety ( 13 Reports)|Feeling Abnormal ( 13 Reports)|Night Sweats ( 13 Reports)|